Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Improving Efficacy and Safety of Agonistic Anti-CD40 Antibody Through Extracellular Matrix Affinity.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Improving Efficacy and Safety of Agonistic Anti-CD40 Antibody Through Extracellular Matrix Affinity.
Improving Efficacy and Safety of Agonistic Anti-CD40 Antibody Through Extracellular Matrix Affinity. Mol Cancer Ther. 2018 11; 17(11):2399-2411.
View in:
PubMed
subject areas
Animals
Antibodies, Monoclonal
Antibody Affinity
beta Catenin
B-Lymphocytes
CD40 Antigens
Cell Line, Tumor
Cross-Priming
Dendritic Cells
Extracellular Matrix
Humans
Immunity
Melanoma, Experimental
Mice, Inbred C57BL
Mice, Nude
Peptides
Placenta Growth Factor
T-Lymphocytes
authors with profiles
Thomas F. Gajewski
Jeffrey Hubbell
Melody Swartz
Martina Damo